Brain MRIs migraine sufferers reveal abnormalities in cortical thickness and some surface area. These measurements could improve understanding of migraines.
Magnetic resonance imaging of brains of patients with migraines reveals abnormalities in cortical thickness and some surface area, according to a study published online in the journal Radiology.
Italian researchers used MRI to acquire T2-weighted and 3-D T1-weighted brain images from 81 subjects - 63 patients who had migraines and 18 healthy controls -to assess cortical thickness and surface area abnormalities in patients with migraine. These are two components of cortical volume that provide different and complementary pieces of information, Massimo Filippi, MD, said in a release. Filippi is the director of the Neuroimaging Research Unit at the University Ospedale San Raffaele and professor of neurology at the University Vita-Salute’s San Raffaele Scientific Institute in Milan.
The study’s findings showed that, compared with the controls, patients with migraines had reduced cortical thickness and surface area in regions of the brain that are related to pain processing. There was only a minimal overlap of cortical thickness and cortical surface area abnormalities, with cortical surface area abnormalities being more pronounced and distributed than cortical thickness abnormalities.
Aura and white matter hyperintensities - areas of high intensity on MRI that appear to be most common among migraineurs - was related to the regional distribution of cortical thickness and surface area abnormalities, but not to disease duration and attack frequency.
The study authors acknowledged that more research is required to further understand these findings, but Filippi said, “Accurate measurements of cortical thickness abnormalities could help characterize migraine patients better and improve understanding of the pathophysiological processes underlying the condition.”
Researchers are continuing a longitudinal study of the patient group to assess the stability of the cortical abnormalities, as well as the effects of treatments on the observed modifications of cortical folding. They are also looking at children who have migraines, to see if the abnormalities could be a biomarker.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).